title: Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein.
abstract: Medical countermeasures to prevent or treat smallpox are needed due to the potential use of poxviruses as biological weapons. Safety concerns with the currently available smallpox vaccine indicate a need for research on alternative poxvirus vaccine strategies. Molecular vaccines involving the use of proteins and/or genes and recombinant antibodies are among the strategies under current investigation. The poxvirus L1 protein, encoded by the L1R open reading frame, is the target of neutralizing antibodies and has been successfully used as a component of both protein subunit and DNA vaccines. L1-specific monoclonal antibodies (e.g., mouse monoclonal antibody mAb-7D11, mAb-10F5) with potent neutralizing activity bind L1 in a conformation-specific manner. This suggests that proper folding of the L1 protein used in molecular vaccines will affect the production of neutralizing antibodies and protection. Here, we co-crystallized the Fab fragment of mAb-7D11 with the L1 protein. The crystal structure of the complex between Fab-7D11 and L1 reveals the basis for the conformation-specific binding as recognition of a discontinuous epitope containing two loops that are held together by a disulfide bond. The structure of this important conformational epitope of L1 will contribute to the development of molecular poxvirus vaccines and also provides a novel target for anti-poxvirus drugs. In addition, the sequence and structure of Fab-7D11 will contribute to the development of L1-targeted immunotherapeutics.
authors: Structural Biology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 12441 Parklawn Drive, Rockville, MD 20852, USA.
authors: Hua-Poo
authors: HP
authors: Su
authors: Joseph W
authors: JW
authors: Golden
authors: Apostolos G
authors: AG
authors: Gittis
authors: Jay W
authors: JW
authors: Hooper
authors: David N
authors: DN
authors: Garboczi
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000378:metabolism; D000914:Antibodies, Viral / Q000737:chemistry / Q000378:metabolism; D019556:COS Cells; D002460:Cell Line; D002522:Chlorocebus aethiops; D003460:Crystallization; D004268:DNA-Binding Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D000939:Epitopes / Q000737:chemistry; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000737:chemistry / Q000378:metabolism; D051379:Mice; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009500:Neutralization Tests; D011212:Poxviridae / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D011487:Protein Conformation; D014616:Vaccinia virus / Q000276:immunology*; D014709:Vero Cells; D014758:Viral Core Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D004268:DNA-Binding Proteins; D000939:Epitopes; C109350:I1 protein, vaccinia virus; D007140:Immunoglobulin Fab Fragments; D014758:Viral Core Proteins
references: Methods. 2005 May;36(1):25-34
references: 15848072
references: Virology. 1999 Feb 1;254(1):71-80
references: 9927575
references: Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1882-7
references: 16436502
references: Virology. 2005 Oct 10;341(1):91-101
references: 16061267
references: Methods Enzymol. 1997;276:307-26
references: 27754618
references: Acta Crystallogr D Biol Crystallogr. 2005 Jun;61(Pt 6):750-4
references: 15930633
references: Vaccine. 2007 Feb 26;25(10):1814-23
references: 17240007
references: J Virol. 2005 Sep;79(18):11724-33
references: 16140750
references: J Mol Biol. 1993 Dec 20;234(4):946-50
references: 8263940
references: Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18572-7
references: 16339313
references: Acta Crystallogr D Biol Crystallogr. 2005 Apr;61(Pt 4):458-64
references: 15805601
references: J Mol Biol. 1971 Feb 14;55(3):379-400
references: 5551392
references: Virology. 2006 Nov 25;355(2):164-74
references: 16919703
references: Virology. 1999 May 25;258(1):189-200
references: 10329580
references: Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11178-92
references: 15249657
references: Virology. 2005 Oct 10;341(1):59-71
references: 16083934
references: Virology. 2003 Feb 1;306(1):181-95
references: 12620810
references: Virology. 2000 Jan 20;266(2):329-39
references: 10639319
references: J Hyg (Lond). 1970 Jun;68(2):197-210
references: 4988047
references: Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
references: 15299926
references: J Virol. 2004 Oct;78(19):10230-7
references: 15367588
references: J Biol Chem. 1993 Apr 5;268(10):7585-93
references: 8463289
references: Proc Natl Acad Sci U S A. 2002 May 14;99(10):6667-72
references: 11983854
references: Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4240-5
references: 15761054
references: Biochemistry. 2006 Feb 21;45(7):2085-93
references: 16475797
references: Protein Sci. 2006 Feb;15(2):343-51
references: 16434746
references: J Virol. 2005 Aug;79(15):9458-69
references: 16014909
references: Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9
references: 2025413
references: J Virol. 1994 Oct;68(10):6401-10
references: 8083978
references: Virology. 2006 Jan 5;344(1):48-54
references: 16364735
references: Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4152-7
references: 15753319
references: Annu Rev Biochem. 1990;59:439-73
references: 2197980
references: J Immunol. 1995 Apr 15;154(8):3975-84
references: 7706736
references: J Virol. 2004 May;78(9):4433-43
references: 15078924
references: Virol J. 2005 Dec 09;2:91
references: 16336686
references: JAMA. 1999 Jun 9;281(22):2127-37
references: 10367824
references: J Virol. 2005 Nov;79(21):13454-62
references: 16227266
references: Virology. 1995 Aug 1;211(1):53-63
references: 7645236
references: Proc Natl Acad Sci U S A. 1997 May 13;94(10):5018-23
references: 9144182
references: Clin Med Res. 2003 Apr;1(2):87-92
references: 15931293
references: J Immunol. 2006 Aug 15;177(4):2552-64
references: 16888017
references: FASEB J. 1995 Jan;9(1):133-9
references: 7821752
references: Virology. 1994 Aug 1;202(2):834-43
references: 8030246
references: Vaccine. 2007 Jan 26;25(7):1214-24
references: 17098336
references: Virology. 1996 Jun 15;220(2):491-4
references: 8661400